ECM
EDIT icon

ETrade Capital Management’s Editas Medicine EDIT Stock Holding History

ETrade Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,275
Closed -$447K – 798
2019
Q1 		$447K Buy
+18,275
New +$414K 0.01% 573

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ETrade Capital Management's EDIT Position: Q2 2019 in Review

ETrade Capital Management sold out of Editas Medicine (EDIT) in Q2 2019, closing a stake of 18,275 shares — an estimated $447K sold.

ETrade Capital Management first reported a position in EDIT in Q1 2019 and held it in 1 quarter. The position peaked at $447K in Q1 2019. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2019.

  • ETrade Capital Management reported no remaining Editas Medicine position as of Q2 2019 after selling out during the quarter.
  • ETrade Capital Management sold 18,275 Editas Medicine shares in Q2 2019, an estimated $447K.
  • ETrade Capital Management first reported a position in Editas Medicine in Q1 2019 and held it in 1 quarter.
  • ETrade Capital Management's Editas Medicine position peaked at $447K in Q1 2019.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2019.

Based on ETrade Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.